Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$16,784,891
+$2,701,109 QoQ
Shares Held
66,702
+3.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#688
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NorthRock Partners, LLC holds $45,176,274 across 12 Drug Manufacturers - General names. ABBV ranks #1 (37.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
66,702 | $16,784,891 | |
| 2 | JNJ |
Johnson & Johnson
|
36,605 | $9,296,571 | |
| 3 | LLY |
ELI LILLY & Co
|
7,302 | $8,758,238 | |
| 4 | MRK |
Merck & Co., Inc.
|
36,249 | $4,657,996 | |
| 5 | AMGN |
Amgen Inc
|
6,203 | $2,246,230 | |
| 6 | AZN |
Astrazeneca PLC
|
3,462 | $656,464 | |
| 7 | NVO |
Novo Nordisk A S
|
12,559 | $602,078 | |
| 8 | PFE |
Pfizer Inc
|
24,805 | $597,304 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,784,891 | 66,702 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $14,083,782 | 64,756 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,593,199 | 63,868 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $19,233,333 | 83,067 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,255,059 | 76,797 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $15,721,961 | 75,038 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $12,947,932 | 72,864 | Shares | Sole | 2025-04-22 | |
| 2024-09-30 | $14,614,112 | 74,003 | Shares | Sole | 2025-04-22 | |
| 2024-06-30 | $12,702,085 | 74,056 | Shares | Sole | 2025-04-22 | |
| 2024-03-31 | $13,503,989 | 74,157 | Shares | Sole | 2025-04-22 | |
| 2023-12-31 | $11,290,804 | 72,858 | Shares | Sole | 2025-04-22 | |
| 2023-09-30 | $3,441,646 | 23,089 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $2,842,264 | 21,096 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $4,197,008 | 26,335 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $4,112,974 | 25,450 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $4,043,076 | 30,125 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $4,913,679 | 32,082 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $5,757,498 | 35,516 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $9,613,806 | 71,003 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $7,397,940 | 68,582 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,327,569 | 65,053 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $7,055,294 | 65,194 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $7,101,902 | 66,280 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $5,638,869 | 64,378 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $6,300,996 | 64,178 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,701,075 | 61,702 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||